Galapagos NV
GLPG
#4738
Rank
A$2.86 B
Marketcap
A$42.69
Share price
-1.14%
Change (1 day)
11.97%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -A$0.82 Billion

According to Galapagos NV's latest financial reports the company's current earnings are A$0.32 Billion. In 2024 the company made an earning of -A$8.39 Million, an increase over its 2023 earnings that were of -A$48.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.82 Billion9673.09%
2024 -A$8.39 Million-82.77%
2023 -A$48.68 Million-85.59%
2022 -A$0.34 Billion60.71%
2021 -A$0.22 Billion-60.08%
2020 -A$0.53 Billion-331.44%
2019 A$0.22 B-523.76%
2018 -A$53.7 Million-72.34%
2017 -A$0.2 Billion-329.59%
2016 A$84.56 M-144.3%
2015 -A$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.68 B-6,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.28 B-1,690.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$9.57 B-1,339.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.17 B-1,546.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$32.53 B-4,311.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.47 B-2,749.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.35 B-1,958.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-A$77.6 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.12 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel